UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 444

Sortiert nach

FODMAP diet modulates visceral nociception by lipopolysaccharide-mediated intestinal inflammation and barrier dysfunction

The Journal of clinical investigation, 2018-01, Vol.128 (1), p.267-280

2018

Link zum Volltext

Verfügbarkeit prüfen

Serum Amyloid A Proteins Induce Pathogenic Th17 Cells and Promote Inflammatory Disease

Cell, 2020-01, Vol.180 (1), p.79-91.e16

2020

Link zum Volltext

Verfügbarkeit prüfen

Irritable bowel syndrome: methods, mechanisms, and pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome

American journal of physiology: Gastrointestinal and liver physiology, 2012-10, Vol.303 (7), p.G775-G785

2012

Link zum Volltext

Verfügbarkeit prüfen

Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation

Gut, 2014-05, Vol.63 (5), p.744-752

2014

Link zum Volltext

Verfügbarkeit prüfen

Biomarkers of Inflammation in Inflammatory Bowel Disease

Gastroenterology (New York, N.Y. 1943), 2015-10, Vol.149 (5), p.1275-1285.e2

Sands, Bruce E

2015

Link zum Volltext

Verfügbarkeit prüfen

Microbial metabolites in health and disease: Navigating the unknown in search of function

The Journal of biological chemistry, 2017-05, Vol.292 (21), p.8553-8559

2017

Link zum Volltext

Verfügbarkeit prüfen

Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome

Journal of gastroenterology and hepatology, 2010-08, Vol.25 (8), p.1366-1373

2010

Link zum Volltext

Verfügbarkeit prüfen

Relationship between vagal tone, cortisol, TNF-alpha, epinephrine and negative affects in Crohn's disease and irritable bowel syndrome

PloS one, 2014-09, Vol.9 (9), p.e105328-e105328

2014

Link zum Volltext

Verfügbarkeit prüfen

Mechanisms and efficacy of dietary FODMAP restriction in IBS

Nature reviews. Gastroenterology & hepatology, 2014-04, Vol.11 (4), p.256

2014

Link zum Volltext

Verfügbarkeit prüfen

Stress and the Microbiota–Gut–Brain Axis in Visceral Pain: Relevance to Irritable Bowel Syndrome

CNS neuroscience & therapeutics, 2016-02, Vol.22 (2), p.102-117

2016

Link zum Volltext

Verfügbarkeit prüfen

Taste receptors of the gut: emerging roles in health and disease

Gut, 2014-01, Vol.63 (1), p.179-190

Depoortere, Inge

2014

Link zum Volltext

Verfügbarkeit prüfen

Melatonin for the treatment of irritable bowel syndrome

World journal of gastroenterology : WJG, 2014-03, Vol.20 (10), p.2492-2498

2014

Link zum Volltext

Verfügbarkeit prüfen

Antibiotic treatment-induced dysbiosis differently affects BDNF and TrkB expression in the brain and in the gut of juvenile mice

PloS one, 2019-02, Vol.14 (2), p.e0212856-e0212856

2019

Link zum Volltext

Verfügbarkeit prüfen

Cytokine imbalance in irritable bowel syndrome: a systematic review and meta‐analysis

Neurogastroenterology and motility, 2014-07, Vol.26 (7), p.1036-1048

2014

Link zum Volltext

Verfügbarkeit prüfen

A Clinicopathologic Study of 24 Cases of Systemic Mastocytosis Involving the Gastrointestinal Tract and Assessment of Mucosal Mast Cell Density in Irritable Bowel Syndrome and Asymptomatic Patients

The American journal of surgical pathology, 2014-06, Vol.38 (6), p.832-843

2014

Link zum Volltext

Verfügbarkeit prüfen

Role of toll like receptors in irritable bowel syndrome: differential mucosal immune activation according to the disease subtype

PloS one, 2012-08, Vol.7 (8), p.e42777-e42777

2012

Link zum Volltext

Verfügbarkeit prüfen

Effect of increased bile acid synthesis or fecal excretion in irritable bowel syndrome-diarrhea

The American journal of gastroenterology, 2014-10, Vol.109 (10), p.1621-1630

2014

Link zum Volltext

Verfügbarkeit prüfen

A sustained hypothalamic–pituitary–adrenal axis response to acute psychosocial stress in irritable bowel syndrome

Psychological medicine, 2014-10, Vol.44 (14), p.3123-3134

2014

Link zum Volltext

Verfügbarkeit prüfen

Tight junctions and IBS ‐ the link between epithelial permeability, low‐grade inflammation, and symptom generation?

Neurogastroenterology and motility, 2014-03, Vol.26 (3), p.296-302

Piche, T.

2014

Link zum Volltext

Verfügbarkeit prüfen

Beneficial effects of Rifaximin in post‐infectious irritable bowel syndrome mouse model beyond gut microbiota

Journal of gastroenterology and hepatology, 2018-02, Vol.33 (2), p.443-452

2018

Link zum Volltext

Verfügbarkeit prüfen

Brain-derived neurotrophic factor contributes to abdominal pain in irritable bowel syndrome

Gut, 2012-05, Vol.61 (5), p.685-694

2012

Link zum Volltext

Verfügbarkeit prüfen

Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice

Gut, 2006-02, Vol.55 (2), p.182-190

2006

Link zum Volltext

Verfügbarkeit prüfen

Metabolomics of Fecal Extracts Detects Altered Metabolic Activity of Gut Microbiota in Ulcerative Colitis and Irritable Bowel Syndrome

Journal of proteome research, 2011-09, Vol.10 (9), p.4208-4218

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 444

Suche als RSS-Feed

Aktive Filter

SpracheJapanisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(431)
Mit Volltextzugriff
(395)

Publikationsform

Artikel
(444)

Sprache

Englisch
(443)

Erscheinungsjahr

n.n

Thema

Science & Technology
(428)
Life Sciences & Biomedicine
(385)
Irritable Bowel Syndrome
(356)
Humans
(304)
Animals
(223)
Gastroenterology
(204)
Male
(183)
Gastroenterology & Hepatology
(181)
Female
(128)
Irritable Bowel Syndrome - Metabolism
(111)
Intestine
(93)
Physiology
(93)
Adult
(92)
Hepatology
(89)
Microbiota
(84)
Metabolism
(82)
Rats
(82)
Inflammatory Bowel Disease
(76)
Middle Aged
(74)
Inflammation
(72)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Longitudinal Multi-omics Reveals Subset-Specific Mechanisms Underlying Irritable Bowel Syndrome

FODMAP diet modulates visceral nociception by lipopolysaccharide-mediated intestinal inflammation and barrier dysfunction

Serum Amyloid A Proteins Induce Pathogenic Th17 Cells and Promote Inflammatory Disease

Irritable bowel syndrome: methods, mechanisms, and pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome

Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation

Biomarkers of Inflammation in Inflammatory Bowel Disease

Microbial metabolites in health and disease: Navigating the unknown in search of function

Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome

Relationship between vagal tone, cortisol, TNF-alpha, epinephrine and negative affects in Crohn's disease and irritable bowel syndrome

Mechanisms and efficacy of dietary FODMAP restriction in IBS

Stress and the Microbiota–Gut–Brain Axis in Visceral Pain: Relevance to Irritable Bowel Syndrome

Taste receptors of the gut: emerging roles in health and disease

Melatonin for the treatment of irritable bowel syndrome

Antibiotic treatment-induced dysbiosis differently affects BDNF and TrkB expression in the brain and in the gut of juvenile mice

Cytokine imbalance in irritable bowel syndrome: a systematic review and meta‐analysis

A Clinicopathologic Study of 24 Cases of Systemic Mastocytosis Involving the Gastrointestinal Tract and Assessment of Mucosal Mast Cell Density in Irritable Bowel Syndrome and Asymptomatic Patients

Role of toll like receptors in irritable bowel syndrome: differential mucosal immune activation according to the disease subtype

5-oxoETE triggers nociception in constipation-predominant irritable bowel syndrome through MAS-related G protein-coupled receptor D

Effect of increased bile acid synthesis or fecal excretion in irritable bowel syndrome-diarrhea

A sustained hypothalamic–pituitary–adrenal axis response to acute psychosocial stress in irritable bowel syndrome

Tight junctions and IBS ‐ the link between epithelial permeability, low‐grade inflammation, and symptom generation?

Beneficial effects of Rifaximin in post‐infectious irritable bowel syndrome mouse model beyond gut microbiota

Brain-derived neurotrophic factor contributes to abdominal pain in irritable bowel syndrome

Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice

Metabolomics of Fecal Extracts Detects Altered Metabolic Activity of Gut Microbiota in Ulcerative Colitis and Irritable Bowel Syndrome

Aktive Filter

Suchergebnisse filtern